{
  "symbol": "ICLR",
  "company_name": "Icon Plc",
  "ir_website": "https://investor.iconplc.com/",
  "structured_data": [
    {
      "section_name": "Recent News",
      "links": [
        {
          "title": "ICON plc to Present at the Jefferies London Healthcare Conference",
          "url": "https://investor.iconplc.com/news-releases/news-release-details/icon-plc-present-jefferies-london-healthcare-conference",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![](/sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/img/ICON_positive_logo.svg) ](http://www.iconplc.com/)\n\n[ ![](/sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/img/ICON_positive_logo.svg) ](http://www.iconplc.com/)\n\n[![](sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/img/ICON_positive_logo.svg) ](http://www.iconplc.com/)\n\n  * [Home](https://www.iconplc.com/)\n  * [Investors](/)\n  * [Stock](/stock-information)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Ownership Profile](/stock-information/ownership-profile)\n    * [Historic Stock Lookup](/stock-information/historic-stock-lookup)\n    * [Investment Calculator](/stock-information/investment-calculator)\n    * [Key Ratios](/stock-information/key-ratios)\n    * [Dividend History](/stock-information/dividend-history)\n  * [Recent News](/investor-releases)\n  * [Financials](/financials-filings)\n    * [Financial Information](/financials-filings/financial-information)\n    * [SEC Filings](/financials-filings/sec-filings)\n    * [Quarterly Results](/financials-filings/quarterly-results)\n    * [Annual Reports](/financials-filings/annual-reports)\n    * [Proxy Materials](/financials-filings/proxy-materials)\n  * [Events](/events-presentations)\n  * [Governance](/corporate-governance)\n    * [Board of Directors](/corporate-governance/board-of-directors)\n    * [Executive Management](https://www.iconplc.com/about/leadership)\n    * [Articles & Committee Charters](/corporate-governance/articles-committee-charters)\n    * [Committee Composition](/corporate-governance/committee-composition)\n    * [Governance Documents](/corporate-governance/governance-documents)\n  * [Resources](/investor-resources)\n    * [ESG](https://www.iconplc.com/about/esg)\n    * [FAQs](/investor-resources/faqs)\n    * [Analyst Coverage](/investor-resources/analyst-coverage)\n    * [Investor Contact](/investor-contact)\n    * [Email Alerts](/email-alerts)\n\n\n\n  * #  News Release \n\n\n\n\n« [Back](#)\n\n## \n\nICON plc to Present at the Jefferies London Healthcare Conference\n\nNovember 13, 2024 \n\n[PDF Version](/node/17461/pdf)\n\nDUBLIN--(BUSINESS WIRE)--Nov. 13, 2024-- [ICON plc](https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.iconplc.com%2F&esheet=54151139&newsitemid=20241112525366&lan=en-US&anchor=ICON+plc&index=1&md5=43aed590da26dd3832cf189615872808), (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc and Mr. Nigel Clerkin, CFO of ICON plc will present at the Jefferies London Healthcare Conference on Thursday, November 21, 2024 at 8:00am GMT. \n\nAny changes to this event and links to the live webcast will be posted on the Investor section of our website under “[Events](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Finvestor.iconplc.com%2Fevents-presentations&esheet=54151139&newsitemid=20241112525366&lan=en-US&anchor=Events&index=2&md5=5c1c1c16d8d3f7fd407ec1aed292bac5)”. \n\n**About ICON plc**\n\nICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 42,250 employees in 106 locations in 55 countries as at September 30, 2024. For further information about ICON, visit: [www.iconplc.com](https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.iconplc.com&esheet=54151139&newsitemid=20241112525366&lan=en-US&anchor=www.iconplc.com&index=3&md5=8cc1e250aae361e5803eeba42474d059). \n\nThis press release contains forward-looking statements, including statements about our financial guidance. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as other economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word \"expected\" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at [http://www.sec.gov](https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.sec.gov&esheet=54151139&newsitemid=20241112525366&lan=en-US&anchor=http%3A%2F%2Fwww.sec.gov&index=4&md5=3943da488cd3c5d8e8252c10c93ab25b). \n\n**ICON/ICLR-G**\n\n![](https://cts.businesswire.com/ct/CT?id=bwnews&sty=20241112525366r1&sid=acqr8&distro=nx&lang=en)\n\nView source version on [businesswire.com](http://businesswire.com): <https://www.businesswire.com/news/home/20241112525366/en/>\n\nKate Haven Vice President Investor Relations +1888 381 7923 \n\nSource: ICON plc\n\n[](javascript:window.print\\(\\); \"Print Page\")\n\n[](# \"Email Page\")\n\n[](/email-alerts \"Email Alerts\")\n\n[](/download-library \"Download Library\")\n\n[](/rss-feeds \"RSS Feeds\")\n\n[](/investor-contact \"Investor Contact\")\n\n### Search Investor\n\n×\n\n![Company Logo](https://cdn.cookielaw.org/logos/b9c99e69-86de-482e-9596-2840b3870459/f19c3466-61df-48e8-a9b7-1f89d737879a/1c36b599-c888-418e-9f20-599da9ab00f5/_ICON_Logo_115x25.png)\n\n## ICON Cookies\n\nBy clicking “Accept All Cookies,” you agree to the storing of cookies on your device to enhance site navigation and user experience, analyze site usage, and assist in our marketing efforts. \n\nAccept All Cookies\n\nCookies Settings\n\n![Company Logo](https://cdn.cookielaw.org/logos/b9c99e69-86de-482e-9596-2840b3870459/1f602449-c73b-41db-a428-9a28ed8761cb/1554f76e-aec1-4e5f-b8af-a6643f61b76c/iconLogo.png)\n\n## ICON Privacy Preference Centre\n\n  * ### Your Privacy\n\n  * ### Strictly Necessary Cookies\n\n  * ### Performance Cookies\n\n  * ### Functional Cookies\n\n  * ### Targeting Cookies\n\n\n\n\n#### Your Privacy\n\nWhen you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because ICON respects your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. Note, however, that blocking some types of cookies may impact your experience of the site and the services we are able to offer. [Cookie Notice](/site-cookies)\n\nUser ID:  e8cc7c02-1825-4010-8da0-d81b53449027\n\n#### Strictly Necessary Cookies\n\nAlways Active\n\nThese cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.\n\nCookies Details‎\n\n#### Performance Cookies\n\nPerformance Cookies\n\nThese cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.\n\nCookies Details‎\n\n#### Functional Cookies\n\nFunctional Cookies\n\nThese cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.\n\nCookies Details‎\n\n#### Targeting Cookies\n\nTargeting Cookies\n\nThese cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.\n\nCookies Details‎\n\nBack Button\n\n### Cookie List\n\nFilter Button\n\nConsent Leg.Interest\n\ncheckbox label label\n\ncheckbox label label\n\ncheckbox label label\n\nClear\n\ncheckbox label label\n\nApply Cancel\n\nConfirm My Choices\n\nReject All Allow All\n\n[![Powered by Onetrust](https://cdn.cookielaw.org/logos/static/powered_by_logo.svg)](https://www.onetrust.com/products/cookie-consent/)\n"
        }
      ]
    },
    {
      "section_name": "Financial Reports",
      "links": [
        {
          "title": "Annual Reports",
          "url": "https://investor.iconplc.com/financials-filings/annual-reports",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![](/sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/img/ICON_positive_logo.svg) ](http://www.iconplc.com/)\n\n[ ![](/sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/img/ICON_positive_logo.svg) ](http://www.iconplc.com/)\n\n[![](sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/img/ICON_positive_logo.svg) ](http://www.iconplc.com/)\n\n  * [Home](https://www.iconplc.com/)\n  * [Investors](/)\n  * [Stock](/stock-information)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Ownership Profile](/stock-information/ownership-profile)\n    * [Historic Stock Lookup](/stock-information/historic-stock-lookup)\n    * [Investment Calculator](/stock-information/investment-calculator)\n    * [Key Ratios](/stock-information/key-ratios)\n    * [Dividend History](/stock-information/dividend-history)\n  * [Recent News](/investor-releases)\n  * [Financials](/financials-filings)\n    * [Financial Information](/financials-filings/financial-information)\n    * [SEC Filings](/financials-filings/sec-filings)\n    * [Quarterly Results](/financials-filings/quarterly-results)\n    * [Annual Reports](/financials-filings/annual-reports)\n    * [Proxy Materials](/financials-filings/proxy-materials)\n  * [Events](/events-presentations)\n  * [Governance](/corporate-governance)\n    * [Board of Directors](/corporate-governance/board-of-directors)\n    * [Executive Management](https://www.iconplc.com/about/leadership)\n    * [Articles & Committee Charters](/corporate-governance/articles-committee-charters)\n    * [Committee Composition](/corporate-governance/committee-composition)\n    * [Governance Documents](/corporate-governance/governance-documents)\n  * [Resources](/investor-resources)\n    * [ESG](https://www.iconplc.com/about/esg)\n    * [FAQs](/investor-resources/faqs)\n    * [Analyst Coverage](/investor-resources/analyst-coverage)\n    * [Investor Contact](/investor-contact)\n    * [Email Alerts](/email-alerts)\n\n\n\n  * #  Annual Reports \n\n\n\n\nNASDAQ: ICLR  $210.25 0 (0.00%)\n\nNASDAQ: ICLR $210.25 0 (0.00%)\n\n#  Annual Reports \n\nTitle | Type  \n---|---  \n[ICON plc 2023 IFRS Annual Report](/static-files/59f123fd-ad38-405d-bc57-630c7d332e24) |  [ICON PLC_IFRS FS_2023.pdf](/static-files/59f123fd-ad38-405d-bc57-630c7d332e24) 5.2 MB  \n[ICON plc 2023 20-F](/static-files/afc935bd-8458-4acb-8837-ad07a6dc9966) |  [ICON plc 2023 20-F](/static-files/afc935bd-8458-4acb-8837-ad07a6dc9966 \"ICON_PLC_20-F_2023_rv2_ao.pdf\") 4.1 MB  \n[ICON plc 2022 IFRS Annual Report ](/static-files/a3bba45f-53eb-4e36-a6d0-a84a7bda3ccf) |  [ICON plc 2022 IFRS Annual Report ](/static-files/a3bba45f-53eb-4e36-a6d0-a84a7bda3ccf \"ICON PLC_IFRS_2023__BR version.pdf\") 3.7 MB  \n[ICON plc 2022 20-F](/static-files/552555e3-0268-4034-b8a4-d5385a5cff28) |  [ICON plc 2022 20-F](/static-files/552555e3-0268-4034-b8a4-d5385a5cff28 \"ICON PLC_20F_2023_BR version.pdf\") 7.2 MB  \n[ICON plc 2021 IFRS Annual Report ](/static-files/312d8c89-773c-4a2b-b268-e71f8184f5d0) |  [ICON plc 2021 IFRS Annual Report ](/static-files/312d8c89-773c-4a2b-b268-e71f8184f5d0 \"IFRS Financial Statements 2021 17-06-2022 FINAL DOC_v1_FINAL_MS.pdf\") 3.4 MB  \n[ICON plc 2021 20-F](/static-files/ea804481-a103-4efa-afe5-b5200ca3225f) |  [ICON plc 2021 20-F](/static-files/ea804481-a103-4efa-afe5-b5200ca3225f \"ICON PLC_20F_2022 - Final Print Version from Broadridge.pdf\") 4 MB  \n[ICON plc 2020 IFRS Annual Report](/static-files/10610c92-fb50-4357-9e8d-70c93e4bb2b3) |  [ICON plc IFRS 2020.PDF](/static-files/10610c92-fb50-4357-9e8d-70c93e4bb2b3) 1.2 MB  \n[ICON plc 2020 20-F ](/static-files/8ad7c47b-c7a2-4ef0-b7d8-b70e92084def) |  [ICON plc 20-F 2020.PDF](/static-files/8ad7c47b-c7a2-4ef0-b7d8-b70e92084def) 1.8 MB  \n[ICON plc 2019 IFRS Annual Report ](/static-files/618a4609-9f24-46de-9a21-fe7e39adc6bb) |  [ICON plc IFRS 2019 ](/static-files/618a4609-9f24-46de-9a21-fe7e39adc6bb \"ICON PLC IFRS 2019 Print.pdf\") 2 MB  \n[ICON plc 2019 20-F](/static-files/305a7ddb-d847-4b54-a7af-c5cc141d76b5) |  [ICON plc 20-F 2019 ](/static-files/305a7ddb-d847-4b54-a7af-c5cc141d76b5 \"ICON PLC 20-F 2019 Print.pdf\") 2 MB  \n[ICON plc 2018 IFRS Annual Report ](/static-files/60295d77-a12a-4b08-82cc-fe4a8e16de42) |  [ICON plc 2018 IFRS Annual Report ](/static-files/60295d77-a12a-4b08-82cc-fe4a8e16de42 \"ICON plc 2018 IFRS Print.pdf\") 2.1 MB  \n[ICON plc 2018 20-F](/static-files/d23ba487-9a18-42b0-a5b7-00f43c3848a5) |  [ICON plc 2018 20-F](/static-files/d23ba487-9a18-42b0-a5b7-00f43c3848a5 \"ICON plc 2018 20-F Print.pdf\") 1.6 MB  \n[ICON plc 2017 IFRS Annual Report](/static-files/d577c6ba-afa5-40e2-a6c5-10f73c399248) |  [ICON plc 2017 IFRS Annual Report](/static-files/d577c6ba-afa5-40e2-a6c5-10f73c399248 \"ICON_plc_2017_IFRS_Annual_Report.pdf\") 667.2 KB  \n[ICON plc 2017 20-F](/static-files/d04c57c3-ffce-4e77-a483-5566f301ca61) |  [ICON plc 2017 20-F](/static-files/d04c57c3-ffce-4e77-a483-5566f301ca61 \"ICON_plc_2017_20-F.pdf\") 1.3 MB  \n[ICON plc 2016 IFRS Annual Report](/static-files/06a27fab-1965-4740-bcc2-e6090eea898d) |  [ICON plc 2016 IFRS Annual Report](/static-files/06a27fab-1965-4740-bcc2-e6090eea898d \"ICON_plc_2016_IFRS_Annual_Report.pdf\") 1.2 MB  \n[ICON plc 2016 20-F](/static-files/8ebc418a-c1a3-4f4d-b607-7edef668da4a) |  [ICON plc 2016 20-F](/static-files/8ebc418a-c1a3-4f4d-b607-7edef668da4a \"ICON_plc_2016_20-F_Final_Filed_28_February_2017.pdf\") 862.5 KB  \n[ICON plc 2015 IFRS Annual Report](/static-files/50e588a4-834b-4d3b-9e82-65a8f57e62ee) |  [ICON plc 2015 IFRS Annual Report](/static-files/50e588a4-834b-4d3b-9e82-65a8f57e62ee \"ICON_plc_2015_Annual_Report.pdf\") 588.1 KB  \n[ICON plc 2015 20-F](/static-files/4367aa75-8dc9-4b5f-975c-d13c84fc7bd6) |  [ICON plc 2015 20-F](/static-files/4367aa75-8dc9-4b5f-975c-d13c84fc7bd6 \"ICON_plc_2015_20-F.pdf\") 757.8 KB  \n[ICON plc 2014 IFRS Annual Report](/static-files/52c7a398-b385-4131-a6d8-178339729ffb) |  [ICON plc 2014 IFRS Annual Report](/static-files/52c7a398-b385-4131-a6d8-178339729ffb \"ICON_plc_IFRS_2014_Annual_Report.pdf\") 2.3 MB  \n[ICON plc 2014 20F](/static-files/9be57521-ffb9-471c-8bfd-9d8f0b74a454) |  [ICON plc 2014 20F](/static-files/9be57521-ffb9-471c-8bfd-9d8f0b74a454 \"ICON_plc_2014_20F.PDF\") 2.4 MB  \n[ICON plc IFRS Annual Report 2013](/static-files/f96b2663-5e16-4f7c-bfef-9d8c5518f891) |  [ICON plc IFRS Annual Report 2013](/static-files/f96b2663-5e16-4f7c-bfef-9d8c5518f891 \"ICON_plc_IFRS_Annual_Report_2013.pdf\") 752.2 KB  \n[ICON plc 2013 20F](/static-files/99046c42-9820-4f84-b918-75fb48c5d97b) |  [ICON plc 2013 20F](/static-files/99046c42-9820-4f84-b918-75fb48c5d97b \"ICON_2013_20F_FINAL.pdf\") 611.6 KB  \n[ICON plc IFRS Annual Report 2012](/static-files/d54a62ca-1c50-44a1-a104-9039fcb7c676) |  [ICON plc IFRS Annual Report 2012](/static-files/d54a62ca-1c50-44a1-a104-9039fcb7c676 \"ICON_plc_IFRS_2012_Annual_Report.pdf\") 756.8 KB  \n[ICON plc 2012 20F](/static-files/627030a9-cbb4-4a71-8e9a-d7c2fd799b14) |  [ICON plc 2012 20F](/static-files/627030a9-cbb4-4a71-8e9a-d7c2fd799b14 \"2012_20F.PDF\") 595.3 KB  \n[ICON plc 2011 20-F](/static-files/e3b2b985-14a0-442d-b65a-9179a89b62e1) |  [ICON plc 2011 20-F](/static-files/e3b2b985-14a0-442d-b65a-9179a89b62e1 \"ICON_plc_Form_20-F_2011.pdf\") 674.6 KB  \n[2011 Annual Report](/static-files/cefe7f78-4803-4f5c-b6c4-8c55827318fd) |  [2011 Annual Report](/static-files/cefe7f78-4803-4f5c-b6c4-8c55827318fd \"ICON_plc_Annual_Report_2011.pdf\") 727.6 KB  \n[2010 Annual Report](/static-files/32129f01-c06e-4623-ad6d-fddddb107abe) |  [2010 Annual Report](/static-files/32129f01-c06e-4623-ad6d-fddddb107abe \"ICON_plc_IFRS_Annual_Report_2010.pdf\") 2.4 MB  \n[2010 20-F](/static-files/ceb244e0-cb6a-48bb-9a91-c8d601b49aac) |  [2010 20-F](/static-files/ceb244e0-cb6a-48bb-9a91-c8d601b49aac \"ICON_plc_Form_20-F_2010.pdf\") 2 MB  \n[2009 Annual Report](/static-files/3024a904-3e35-41ef-b1de-5d8753d09315) |  [2009 Annual Report](/static-files/3024a904-3e35-41ef-b1de-5d8753d09315 \"ICON_plc_Annual_Report_2009.pdf\") 1.2 MB  \n[2009 20 F](/static-files/8f7264cd-330d-4878-83ef-e374fde40a51) |  [2009 20 F](/static-files/8f7264cd-330d-4878-83ef-e374fde40a51 \"ICON_Form_20-F_2009.pdf\") 2.6 MB  \n[2008 20-F](/static-files/3f082179-73de-4fa2-a77c-c05f82365983) |  [2008 20-F](/static-files/3f082179-73de-4fa2-a77c-c05f82365983 \"200820f.pdf\") 568.3 KB  \n[2008 IFRS Accounts](/static-files/df7bf45d-8692-4760-8b93-7fc98e976f16) |  [2008 IFRS Accounts](/static-files/df7bf45d-8692-4760-8b93-7fc98e976f16 \"AR2008.pdf\") 715.9 KB  \n[2007 20-F](/static-files/a8301446-4ebe-4906-951b-0b36925886b5) |  [2007 20-F](/static-files/a8301446-4ebe-4906-951b-0b36925886b5 \"20F07.pdf\") 2 MB  \n[2007 IFRS Accounts](/static-files/8a396c4e-b52b-4dc5-8ac9-c7e311da7fe8) |  [2007 IFRS Accounts](/static-files/8a396c4e-b52b-4dc5-8ac9-c7e311da7fe8 \"IFRS07.pdf\") 1.2 MB  \n[2008 Letter to stockholders](/static-files/b81bc89e-3c75-44e9-bc47-e7ce6efdd174) |  [2008 Letter to stockholders](/static-files/b81bc89e-3c75-44e9-bc47-e7ce6efdd174 \"lettertostock.pdf\") 119.6 KB  \n[2006 Annual Report](/static-files/9c99bf7b-dbc8-4eb6-bd90-7c667d739e4a) |  [2006 Annual Report](/static-files/9c99bf7b-dbc8-4eb6-bd90-7c667d739e4a \"2006.pdf\") 2.4 MB  \n[2005 Annual Report](/static-files/1317b0fd-ef62-43a4-9e1b-df9b42bfa751) |  [2005 Annual Report](/static-files/1317b0fd-ef62-43a4-9e1b-df9b42bfa751 \"2005.pdf\") 1 MB  \n[2004 Annual Report](/static-files/dd6dd68e-6f95-4be8-a7b2-4ddcc4aca545) |  [2004 Annual Report](/static-files/dd6dd68e-6f95-4be8-a7b2-4ddcc4aca545 \"Annrep20041.pdf\") 2.2 MB  \n[2003 Annual Report](/static-files/95e795dc-d26a-48cf-9222-31d00058bdc0) |  [2003 Annual Report](/static-files/95e795dc-d26a-48cf-9222-31d00058bdc0 \"Annrep20031.pdf\") 588.3 KB  \n[2002 Annual Report](/static-files/ebc1223e-212c-40cf-b53e-cc80cd93136a) |  [2002 Annual Report](/static-files/ebc1223e-212c-40cf-b53e-cc80cd93136a \"Annrep20021.pdf\") 2.9 MB  \n[2001 Annual Report](/static-files/5cd01093-e5f4-413e-812f-9976043491a3) |  [2001 Annual Report](/static-files/5cd01093-e5f4-413e-812f-9976043491a3 \"Annrep20011.pdf\") 3.8 MB  \n[2000 Annual Report](/static-files/ef80b2d6-abe8-4e5d-b4be-eafa415e7179) |  [2000 Annual Report](/static-files/ef80b2d6-abe8-4e5d-b4be-eafa415e7179 \"Annrep20001.pdf\") 2.6 MB  \n[1999 Annual Report](/static-files/aaee09b5-b3eb-4d19-a38f-59e36f436124) |  [1999 Annual Report](/static-files/aaee09b5-b3eb-4d19-a38f-59e36f436124 \"Annrep19991.pdf\") 2 MB  \n  \n[](javascript:window.print\\(\\); \"Print Page\")\n\n[](# \"Email Page\")\n\n[](/email-alerts \"Email Alerts\")\n\n[](/download-library \"Download Library\")\n\n[](/rss-feeds \"RSS Feeds\")\n\n[](/investor-contact \"Investor Contact\")\n\n### Search Investor\n\n×\n"
        }
      ]
    },
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "Press Releases",
          "url": "https://iconplc.com/news-events/press-releases/",
          "content": "[ Skip to main content ](#main-content)\n\n[![Facebook](/themes/custom/iconplc/src/assets/images/social-icons/facebook-f.svg)](/#facebook)[![Facebook](/themes/custom/iconplc/src/assets/images/social-icons/x-twitter.svg)](/#x)[![Facebook](/themes/custom/iconplc/src/assets/images/social-icons/linkedin-in.svg)](/#linkedin)\n\n  1. [Home](/)\n  2. [News & Events](/news-events)\n  3. Press releases \n\n\n\n# Press releases\n\n  * ![icon-building-dublin](https://icon.widen.net/content/kd3uulpxfb/web/icon-building-dublin.jpg?crop=yes&w=545&h=545&itok=XuVOhkZO)\n\n23 October 2024\n\n### [ ICON Reports Third Quarter 2024 Results  ](/news-events/press-releases/ICON-reports-third-quarter-2024-results)\n\nICON plc today reported its financial results for the third quarter ended September 30, 2024\n\n  * ![icon-dublin-office-headquarters](https://icon.widen.net/content/udzs5nykqq/web/icon-dublin-office-headquarters.jpg?crop=yes&w=545&h=545&itok=OHE5SIx2)\n\n27 September 2024\n\n### [ ICON plc Schedules Third Quarter 2024 Earnings Conference Call  ](/news-events/press-releases/icon-plc-schedules-third-quarter-2024-earnings-conference-call)\n\nICON plc today announced that it will release its financial results for the third quarter 2024 after the market closes on Wednesday, October 23, 2024.\n\n  * ![Oncology survey report web assets](https://icon.widen.net/content/xnzlwstnhh/web/Square%20thumbnail_OncologySurveyreport.jpg?crop=yes&w=545&h=545&itok=XGGhlOgo)\n\n12 September 2024\n\n### [ ICON survey highlights scale of focus on precision therapies in increasingly complex oncology landscape  ](/news-events/press-releases/icon-survey-highlights-scale-focus-precision-therapies-increasingly)\n\nICON plc today announced results from a recent survey of over 100 professionals engaged in oncology drug development to understand the current state of emerging oncology treatment development, including the associated clinical trial dynamics.\n\n  * ![exterior-of-icon-hq-building-dublin-ireland](https://icon.widen.net/content/6nlrjleblj/web/exterior-of-icon-hq-building-dublin-ireland?crop=yes&w=545&h=545&itok=mpMndzck)\n\n03 September 2024\n\n### [ ICON plc to present at the Baird 2024 Global Healthcare Conference  ](/news-events/press-releases/icon-plc-present-baird-2024-global-healthcare-conference)\n\nTuesday, 10 September, 2024 at 3:45pm ET. \n\n  * ![ICON_Dublin-Reception](https://icon.widen.net/content/vrggzw7eao/web/ICON_Dublin-Reception.jpg?crop=yes&w=545&h=545&itok=ATSLXcIK)\n\n14 August 2024\n\n### [ ICON Announces appointment of new Chief Financial Officer (CFO)  ](/news-events/press-releases/icon-announces-appointment-new-chief-financial-officer-cfo)\n\nICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced the appointment of Nigel Clerkin as its new Chief Financial Officer (CFO). \n\n  * ![icon-dublin-office-headquarters](https://icon.widen.net/content/udzs5nykqq/web/icon-dublin-office-headquarters.jpg?crop=yes&w=545&h=545&itok=8N_uKMFD)\n\n24 July 2024\n\n### [ ICON Reports Second Quarter 2024 Results  ](/news-events/press-releases/icon-reports-second-quarter-2024-results)\n\nICON plc today reported its financial results for the second quarter ended June 30, 2024.\n\n  * ![icon-dublin-office-hq-building](https://icon.widen.net/content/pmedgzmm9y/web/icon-dublin-office-hq-building.jpg?crop=yes&w=545&h=545&itok=h0NXpN3E)\n\n24 July 2024\n\n### [ ICON announces results of Annual General Meeting and changes to the Board of Directors  ](/news-events/press-releases/icon-announces-results-annual-general-meeting-and-changes-board)\n\nICON plc announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 23, 2024 were duly passed by shareholders.\n\n  * ![ICON_Dublin-Reception](https://icon.widen.net/content/vrggzw7eao/web/ICON_Dublin-Reception.jpg?crop=yes&w=545&h=545&itok=w9yV3vYF)\n\n10 July 2024\n\n### [ ICON recognised for leadership position in clinical research industry and as socially responsible employer  ](/news-events/press-releases/icon-recognised-leadership-position-clinical-research-industry-and)\n\nAt the CRO Leadership Awards 2024, ICON was recognised for its excellence in clinical research in all categories.\n\n  * ![icon-dublin-office-headquarters](https://icon.widen.net/content/udzs5nykqq/web/icon-dublin-office-headquarters.jpg?crop=yes&w=545&h=545&itok=XnJV8LAZ)\n\n01 July 2024\n\n### [ ICON plc schedules second quarter 2024 earnings conference call  ](/news-events/press-releases/icon-plc-schedules-second-quarter-2024-earnings-conference-call)\n\nA conference call and webcast to discuss its financial results and performance on July 25, 2024. \n\n  * ![icon-dublin-office-hq-building](https://icon.widen.net/content/pmedgzmm9y/web/icon-dublin-office-hq-building.jpg?crop=yes&w=545&h=545&itok=rF9OVQ9I)\n\n04 June 2024\n\n### [ ICON plc to Present at the Jefferies Global Healthcare Conference  ](/news-events/press-releases/icon-plc-present-jefferies-global-healthcare-conference)\n\nICON plc today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET.\n\n\n\n\n[ In this section ](#sidebar-content)\n\n###### In this section\n\n  * [Press releases](/news-events/press-releases)\n  * [In the News](/news-events/thought-leadership)\n  * [Mediakit](/news-events/mediakit)\n\n    * [Facts and figures](/news-events/mediakit/facts-and-figures)\n    * [ICON spokespeople](/news-events/mediakit/icon-spokespeople)\n\n  * [Awards](/news-events/awards)\n  * [Events](/news-events/events)\n\n    * [Industry events](/news-events/events/industry-events)\n    * [Webinars](/news-events/events/webinars)\n    * [Workshops](/news-events/events/workshops)\n\n  * [Webinars](/news-events/events/webinars)\n  * [Social media](/news-events/social-media)\n\n\n\n#### Connect with us\n\n  * [ Contact us ](https://iconplc.com/contact/)\n  * [ Submit proposal request ](https://iconplc.com/contact/submit-rfp/)\n  * [ Update Email Preferences ](https://iconplc.com/preferences/)\n  * [ Global office locator ](https://iconplc.com/contact/global-office-locator/)\n  * [ ICON on social media ](https://iconplc.com/news-events/social-media/)\n\n\n\n##  [What’s happening in ICON](/news-events/social-media/)\n\nHow can we help?\n\nDismiss Search Modal\n\n  * All\n  * [Website](#website)\n\n\n\nSearch\n\nPopular search terms:\n\n  * Biotech\n  * Cell and Gene Therapies\n  * Consulting\n  * Early Clinical\n  * Medical Device\n  * Oncology\n  * Rare & Orphan Diseases\n  * Real World Evidence\n  * Site & Patient Recruitment\n  * Strategic Solutions\n  * Regulatory Intelligence\n\n\n\nCategories\n\n✓\n\nThanks for sharing!\n\n[AddToAny](https://www.addtoany.com \"Share Buttons\")\n\n[More…](#addtoany \"Show all\")\n"
        }
      ]
    },
    {
      "section_name": "Events",
      "links": [
        {
          "title": "Upcoming Events",
          "url": "https://investor.iconplc.com/events-presentations",
          "content": ""
        },
        {
          "title": "View Event Details",
          "url": "https://iconplc.com/news-events/events/",
          "content": "[ Skip to main content ](#main-content)\n\n[![Facebook](/themes/custom/iconplc/src/assets/images/social-icons/facebook-f.svg)](/#facebook)[![Facebook](/themes/custom/iconplc/src/assets/images/social-icons/x-twitter.svg)](/#x)[![Facebook](/themes/custom/iconplc/src/assets/images/social-icons/linkedin-in.svg)](/#linkedin)\n\n  1. [Home](/)\n  2. [News & Events](/news-events)\n  3. Events \n\n\n\n# Events\n\n_Filter events by clicking within the ‘Category’ drop-down list._\n\nCategory - Any -IndustryWebinarsWorkshop- Any -\n\n  * Industry \n\n### [ SCDM India  ](/news-events/events/industry-events#68512b3e-1ab8-49b3-a9b1-80cba346e4bc)\n\nDate | 5 December 2024 - 7 December 2024   \n---|---  \nTime |  09:01 - 17:42  \nLocation | Hyderabad, India   \nTimezone | Asia/Kolkata  \n  \n  * Webinars \n\n### [ “S” stands for systematic: Demystifying the systematic literature review ](/news-events/events/webinars/s-stands-systematic-demystifying-systematic-literature-review)\n\nDate | 5 December 2024   \n---|---  \nTime |  11:00 - 12:00  \nLocation | Webinar  \nTimezone | America/New York  \n  \n  * Industry \n\n### [ ASH Annual Meeting  ](/news-events/events/industry-events#2aada30d-508e-4214-a67d-80855cb28316)\n\nDate | 7 December 2024 - 10 December 2024   \n---|---  \nTime |  09:30 - 17:00  \nLocation | San Diego, CA USA  \nTimezone | America/Puerto Rico  \n  \n  * Industry \n\n### [ Global CVCT Forum  ](/news-events/events/industry-events#445d5710-9bca-4435-b5dc-e0729c3ccce5)\n\nDate | 9 December 2024 - 11 December 2024   \n---|---  \nTime |  09:00 - 17:00  \nLocation | Washington, DC USA  \nTimezone | America/New York  \n  \n  * Industry \n\n### [ Disruptive Technology for Clinical Trials Summit Europe ](/news-events/events/industry-events#c77023a2-766d-4c76-a64b-6ece70ce433d)\n\nDate | 28 January 2025   \n---|---  \nTime |  08:00 - 18:00  \nLocation | London, UK  \nTimezone | Europe/London  \n  \nICON will speak\n\n  * Workshop \n\n### [ Beginners/Intermediate Online NONMEM/PDx-Pop workshop ](/news-events/events/workshop/beginners-intermediate-online-nonmempdx-pop-workshop-sep-2024)\n\nDate | 28 January 2025 - 29 January 2025   \n---|---  \nTime |  08:00 - 18:00  \nLocation | Online/Virtual Webex  \nTimezone | America/New York  \n  \n  * Workshop \n\n### [ Advanced Online NONMEM/PDx-Pop workshop ](/news-events/events/workshops/advanced-online-nonmem-pdx-pop-workshop-sep-2024)\n\nDate | 30 January 2025   \n---|---  \nTime |  08:00 - 17:00  \nLocation | Online/Virtual Webex  \nTimezone | America/New York  \n  \n  * Workshop \n\n### [ Beginners/Intermediate Online NONMEM/PDx-Pop workshop ](/news-events/events/workshops/beginners-intermediate-nonmem-pdx-pop-2024)\n\nDate | 20 May 2025 - 21 May 2025   \n---|---  \nTime |  09:00 - 16:00  \nLocation | Online/Virtual Webex  \nTimezone | America/New York  \n  \n  * Workshop \n\n### [ Advanced Online NONMEM/PDx-Pop workshop ](/news-events/events/workshops/advanced-online-nonmem-pdx-pop-workshop-2024)\n\nDate | 22 May 2025   \n---|---  \nTime |  09:00 - 16:00  \nLocation | Online/Virtual Webex  \nTimezone | America/New York  \n  \n\n\n\n[ In this section ](#sidebar-content)\n\n###### In this section\n\n  * [Press releases](/news-events/press-releases)\n  * [In the News](/news-events/thought-leadership)\n  * [Mediakit](/news-events/mediakit)\n\n    * [Facts and figures](/news-events/mediakit/facts-and-figures)\n    * [ICON spokespeople](/news-events/mediakit/icon-spokespeople)\n\n  * [Awards](/news-events/awards)\n  * [Events](/news-events/events)\n\n    * [Industry events](/news-events/events/industry-events)\n    * [Webinars](/news-events/events/webinars)\n    * [Workshops](/news-events/events/workshops)\n\n  * [Webinars](/news-events/events/webinars)\n  * [Social media](/news-events/social-media)\n\n\n\n#### Connect with us\n\n  * [ Contact us ](https://iconplc.com/contact/)\n  * [ Submit proposal request ](https://iconplc.com/contact/submit-rfp/)\n  * [ Update Email Preferences ](https://iconplc.com/preferences/)\n  * [ Global office locator ](https://iconplc.com/contact/global-office-locator/)\n  * [ ICON on social media ](https://iconplc.com/news-events/social-media/)\n\n\n\n##  Related Information \n\n[ Webpage Webinars  ](/news-events/events/webinars)[ Webpage Industry Events  ](/news-events/events/industry-events)[ Webpage Workshops  ](/news-events/events/workshops)\n\n  * 1\n\n\n\n##  [What’s happening in ICON](/news-events/social-media/)\n\nHow can we help?\n\nDismiss Search Modal\n\n  * All\n  * [Website](#website)\n\n\n\nSearch\n\nPopular search terms:\n\n  * Biotech\n  * Cell and Gene Therapies\n  * Consulting\n  * Early Clinical\n  * Medical Device\n  * Oncology\n  * Rare & Orphan Diseases\n  * Real World Evidence\n  * Site & Patient Recruitment\n  * Strategic Solutions\n  * Regulatory Intelligence\n\n\n\nCategories\n\n✓\n\nThanks for sharing!\n\n[AddToAny](https://www.addtoany.com \"Share Buttons\")\n\n[More…](#addtoany \"Show all\")\n"
        }
      ]
    }
  ]
}